Duloxetine HCL EC Pellets-Suitable for filling 20mg, 40mg & 60mg Capsules.
- Release pattern compared with innovator
- MKPPL objective is to develop duloxetine pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents.
- All the ingredients are available for both FBC process and all the equipment’s including analytical instruments like HPLC, FTIR, GC and dissolution apparatus are available to develop duloxetine pellets.
- Offer complete technical package for registrations in all regulated/semi regulated markets.
Share
Additional information
| Percentage | 17%, 20% |
|---|---|
| Release Type | Delayed Release |
| Target Formulations | Capsules |
| Documentation Available: | DMF in CTD Format |
